| Bioactivity | SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer. SOR-C13 has anticancer activity[1]. |
| Name | SOR-C13 |
| CAS | 1187852-48-7 |
| Shortening | KEFLHPSKVDLPR |
| Formula | C72H116N20O19 |
| Molar Mass | 1565.81 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
SOR-C13
CAS: 1187852-48-7 F: C72H116N20O19 W: 1565.81
SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.